Jennifer Borque

Jennifer Borque is a seasoned healthcare sales professional with extensive experience in the pharmaceutical industry. Currently working at Tris Pharma since January 2023, Jennifer markets and sells ADHD medications to various healthcare providers while establishing new business relationships. Previously, Jennifer served as a Neuroscience Specialist at Intra-Cellular Therapies from November 2020 to January 2023, leading the launch of Caplyta for adult patients with schizophrenia and bipolar disorder. Prior experience includes a role at Syneos Health, where Jennifer successfully launched a transdermal technology for schizophrenia treatment and was responsible for growing prescription sales. At Evus Health Solutions, LLC, Jennifer promoted Nitromist to healthcare practitioners across multiple specialties, focusing on market development and account management. Jennifer holds a Bachelor of Arts in Business/Corporate Communications from Trinity International University.